Bouza Carmen, López Teresa, Magro Angeles, Navalpotro Lourdes, Amate José María
Instituto de Salud Carlos III, Agency for Health Technology Assessment, Madrid, Spain.
Eur Spine J. 2006 Jul;15(7):1050-67. doi: 10.1007/s00586-005-0048-x. Epub 2006 Jan 21.
The aim of this study is to evaluate the efficacy and safety of balloon kyphoplasty (BK) in the management of vertebral compression fractures (VCFs). This study is based on a systematic review of the literature (until October 2004) and meta-analysis of clinical studies assessing the efficacy and safety of BK in the treatment of VCFs. Estimates of effect were based on a random effects model. Meta-regression analyses were carried out where required. A total of 26 studies met the inclusion criteria. Although studies displayed considerable methodological limitations, the results of the clinical series indicate significant improvements in pain intensity, vertebral height, sagittal alignment, functional capacity, and quality of life. Compared with conventional medical management, BK afforded significant improvement in pain intensity and mobility. Likewise, a significant reduction was observed in vertebral collapse, kyphotic deformity, the development of new vertebral fractures, and hospital stay. Compared with vertebroplasty, the technique reduced the loss of height and the degree of kyphotic deformity, and afforded a significantly lower leakage rate-with no differences in relation to other variables. Regarding adverse effects, leakage affected 7% of all levels treated, while complications were recorded in 2% of the patients, and new vertebral fractures in 16%. The available evidence suggests that BK can be effective and safe in application to VCFs. However, existing studies evince substantial methodological limitations and relatively short follow-up periods. Better clinical research is required to determine the capacity of BK to avoid the functional and physiological sequelae of VCFs and to define the true role of the technique among the existing therapeutic options.
本研究旨在评估球囊后凸成形术(BK)治疗椎体压缩骨折(VCF)的疗效和安全性。本研究基于对文献的系统回顾(截至2004年10月)以及对评估BK治疗VCF疗效和安全性的临床研究的荟萃分析。效应估计基于随机效应模型。必要时进行了荟萃回归分析。共有26项研究符合纳入标准。尽管研究显示出相当大的方法学局限性,但临床系列结果表明,疼痛强度、椎体高度、矢状位排列、功能能力和生活质量均有显著改善。与传统药物治疗相比,BK在疼痛强度和活动能力方面有显著改善。同样,椎体塌陷、后凸畸形、新椎体骨折的发生以及住院时间均显著减少。与椎体成形术相比,该技术减少了高度丢失和后凸畸形程度,且渗漏率显著降低,在其他变量方面无差异。关于不良反应,7%的治疗节段发生渗漏,2%的患者出现并发症,16%的患者发生新椎体骨折。现有证据表明,BK应用于VCF可能有效且安全。然而,现有研究存在重大方法学局限性且随访期相对较短。需要更好的临床研究来确定BK避免VCF功能和生理后遗症的能力,并确定该技术在现有治疗选择中的真正作用。